Relay Therapeutics (RLAY) Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

Go back to Relay Therapeutics (RLAY) Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
(NASDAQ: RLAY) Delayed: 18.19 --0 (-0%)
Previous Close $18.19    52 Week High
Open $18.19    52 Week Low
Day High $18.19    P/E N/A 
Day Low $18.19    EPS
Volume 1,986